Suraksha Diagnostic Share Price

    NSE
    311.00
    +4.45 (1.62%)
    SURAKSHA • 30 Jul, 2025 | 03:29 PM
    BUY
    The current prices are delayed, login or Open Demat Account for live prices.

    Suraksha Diagnostic Stock Performance

    1W Return0.31
    1Y Return0.00
    Today's Low302
    Prev. Close306.55
    Mkt Cap (Cr.)1,600.70
    1M Return-5.49
    3Y Return0.00
    52-Week High449
    Open304.60
    PE Ratio47.68
    6M Return-0.16
    Today's High311
    52-Week Low231
    Face Value2

    Suraksha Diagnostic Company background

    Founded in: 2005
    Managing director: Somnath Chatterjee
    Suraksha Diagnostic Limited was incorporated as Suraksha Diagnostic Private Limited as a private limited company dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata. Subsequently, Company was converted into a public limited company and the name of Company was changed to Suraksha Diagnostic Limited, and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre. The Company is mainly engaged in running diagnostic centres for carrying out various pathological and radiological testing and medical consultation services in in East India. In addition to integrated pathology and radiology testing services, it also offer omnichannel medical consultation services via online and offline modes to customers through 43 of its diagnostic centres which house 120 polyclinic chambers hosting 750+ doctors. The diagnostic test menu included (a) 788 routine pathology tests ranging from basic biochemistry andhematology to 647 specialized pathology tests such as advanced biochemistry, histopathology, and molecular pathology, and (b) 748 basic/intermediate radiology tests ranging from basic xrays, ultrasonography (USG), and computerized tomography (CT) scans to 104 advanced radiology tests such as magnetic resonance imaging (MRI) scans and specialized CT scans.The first centre of the Company was launched at Kestopur in 2007. The second centre launched at Khardah in 2010, which increased the operating centres to 5. The Company increased the laboratories to 4 and the operating centres rose to 25 in 2016. The Company further acquired the business of Sunwell Diagnostic Private Limited in 2017. The operations to Meghalaya were expanded through a publicprivate partnership with the Government of Meghalaya in 2019. Further, 2 preexisting diagnostic centres in Kolkata were acquired by the Company from Future Medical and Research Trust in 2020. And the first 3T MRI and 128 CT launched at New Town in 2023. The Company is planning the Public Issue upto 19,189,330 Equity Shares through Offer for Sale.

    As of 30 Jul, 2025, Suraksha Diagnostic share price is ₹307.4. The stock opened at ₹304.6 and had closed at ₹306.6 the previous day. During today’s trading session, Suraksha Diagnostic share price moved between ₹302.00 and ₹311.00, with an average price for the day of ₹306.50. Over the last 52 weeks, the stock has recorded a low of ₹231.00 and a high of ₹449.00. In terms of performance, Suraksha Diagnostic share price has increased by 1% over the past six months and has declined by 26.34% over the last year.

    Read More
    View details of Market Depth

    Suraksha Diagnostic Fundamental

    Market Cap (in crs)

    1,600.70

    Face Value

    2

    Turnover (in lacs)

    69.27

    Key Metrics

    Qtr Change %
    31.55% Fall from 52W High
    Dividend yield 1yr %
    0

    Suraksha Diagnostic Key Financials

    View more
    Loading chart...
    Loading chart...
    Loading chart...
    Loading chart...
    Suraksha Diagnostic Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    65.09 Cr
    59.51 Cr
    66.75 Cr
    60.73 Cr
    55.19 Cr
    Suraksha Diagnostic Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022
    255.94 Cr
    222.26 Cr
    193.69 Cr
    225.77 Cr
    Suraksha Diagnostic Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    7.17 Cr
    5.98 Cr
    10.16 Cr
    7.67 Cr
    6.32 Cr
    Suraksha Diagnostic Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022
    30.98 Cr
    23.13 Cr
    6.06 Cr
    20.82 Cr

    Suraksha Diagnostic Result Highlights

    • Suraksha Diagnostic Ltd reported a 6.6% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.

    • Its expenses for the quarter were down by 11.4% QoQ and - - YoY.

    • The net profit increased 5.7% QoQ and - - YoY.

    • The earnings per share (EPS) of Suraksha Diagnostic Ltd - at - during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Suraksha Diagnostic

    Promoter
    48.9%
    Foreign Institutions
    14%
    Mutual Funds
    19.6%
    Domestic Institutions
    22.3%
    Public
    14.8%
    Promoter
    48.8%
    Foreign Institutions
    14.5%
    Mutual Funds
    19.3%
    Domestic Institutions
    22%
    Public
    14.7%
    Promoter
    48.8%
    Foreign Institutions
    15.4%
    Mutual Funds
    17.6%
    Domestic Institutions
    20.4%
    Public
    15.4%

    Suraksha Diagnostic Technical Analysis

    Moving Averages Analysis
    311.00
    Current Price
    Bullish Moving Averages
    2
    Bearish Moving Averages
    12
    5Day EMA
    307.50
    10Day EMA
    310.20
    12Day EMA
    311.30
    20Day EMA
    314.60
    26Day EMA
    316.20
    50Day EMA
    317.60
    100Day EMA
    321.10
    EMA
    5Day SMA
    306.40
    10Day SMA
    311.10
    20Day SMA
    315.60
    30Day SMA
    320.80
    50Day SMA
    324.50
    100Day SMA
    307.00
    150Day SMA
    315.00
    SMA
    Delivery & Volume
    Loading chart...

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    12442 Rs
    23866 Rs
    Week Rs
    13696 Rs
    28397 Rs
    Month Rs
    47551 Rs
    64036 Rs
    306.78
    Pivot
    Resistance
    First Resistance
    311.57
    Second Resistance
    315.78
    Third Resistance
    320.57
    Support
    First Support
    302.57
    Second support
    297.78
    Third Support
    293.57
    Relative Strength Index
    38.94
    Money Flow Index
    24.37
    MACD
    -4.90
    MACD Signal
    -3.69
    Average True Range
    8.67
    Average Directional Index
    19.86
    Rate of Change (21)
    -6.55
    Rate of Change (125)
    0.28
    Name
    Holding Percent
    NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHA
    6.28
    KOTAK SMALL CAP FUND
    5.84
    ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C
    3.79
    BANDHAN BALANCED ADVANTAGE FUND
    1.33
    QUANT MUTUAL FUND - QUANT HEALTHCARE FUND
    1.22
    JM FINANCIAL MUTUAL FUND - JM SMALL CAP FUND
    1.12
    CARNELIAN BHARAT AMRITKAAL FUND .
    2.41
    ORBIMED ASIA II MAURITIUS LIMITED
    12.88

    Suraksha Diagnostic Latest News

    29 JUL 2025 | Tuesday

    Suraksha Diagnostic Ltd - 544293 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    05 JUL 2025 | Saturday

    Suraksha Diagnostic Ltd - 544293 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    04 JUL 2025 | Friday

    Suraksha Diagnostic Ltd - 544293 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    View More

    Suraksha Diagnostic Share Price FAQs

    Suraksha Diagnostic share price is ₹311.00 in NSE and ₹309.50 in BSE as on 30/7/2025.

    Suraksha Diagnostic share price in the past 1-year return was 0. The Suraksha Diagnostic share hit a 1-year low of Rs. 231 and a 1-year high of Rs. 449.

    The market cap of Suraksha Diagnostic is Rs. 1600.7 Cr. as of 30/7/2025.

    The PE ratios of Suraksha Diagnostic is 47.68 as of 30/7/2025.

    The PB ratios of Suraksha Diagnostic is 7.43 as of 30/7/2025

    The Mutual Fund Shareholding in Suraksha Diagnostic was 19.58% at the end of 30/7/2025.

    You can easily buy Suraksha Diagnostic shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Suraksha Diagnostic share price is ₹449 and ₹231 as of 30/7/2025.

    Please be aware that Suraksha Diagnostic stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    61.21
    -0.58 (-0.94%)
    131.40
    -0.82 (-0.62%)
    668.45
    -23.90 (-3.45%)
    2,532.90
    -15.00 (-0.59%)
    150.22
    -0.27 (-0.18%)
    358.40
    -1.10 (-0.31%)
    161.36
    -0.33 (-0.20%)
    303.45
    -3.10 (-1.01%)
    386.50
    -1.75 (-0.45%)
    401.35
    +1.50 (+0.38%)
    Top Gainers
    3,665.10
    +169.50 (+4.85%)
    1,733.80
    +23.30 (+1.36%)
    338.80
    +4.20 (+1.26%)
    12,618.00
    +149.00 (+1.19%)
    1,073.10
    +11.50 (+1.08%)
    Top Losers
    668.45
    -23.90 (-3.45%)
    4,251.30
    -73.90 (-1.71%)
    288.95
    -4.15 (-1.42%)
    8,043.50
    -84.00 (-1.03%)
    303.45
    -3.10 (-1.01%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -